Clinically, patients with an insertion/deletion polymorphism (rs145204276) in the lncRNA GAS5 promoter demonstrate upregulated lncRNA GAS5 expression and have an increased risk of ischemic stroke 29. This evidence concerns the gene GAS5 and ischemic stroke.